Company BrightGene Bio-Medical Technology Co., Ltd.

Company BrightGene Bio-Medical Technology Co., Ltd.

688166

CNE100003PR1

Pharmaceuticals

Equities

688166

CNE100003PR1

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
35.53 ^CNY	-1.93%		-0.59%	+1.51%

05-07	China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7%	MT
05-07	BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%	MT

BrightGene Bio-Medical Technology Co Ltd is a China-based company mainly engaged in the research, development and production of generic drugs and original new drugs. The Company's main products include antifungal active pharmaceutical ingredients (APIs), antiviral APIs, immunosuppressive APIs, and other APIs and preparations. The Company's generic drugs mainly include entecavir, caspofungin, micafungin, posaconazole, everolimus and fondaparinux sodium. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 1,155

CNY in Million	2022	Weight	2023	Weight	Delta
Product 86.8 %	878	86.3 %	1,023	86.8 %	+16.63%
Technology 6.4 %	84	8.3 %	76	6.4 %	-10.17%
Equity Share 5.2 %	51	5.1 %	62	5.2 %	+20.46%
Other Business 1.6 %	4	0.4 %	18	1.6 %	+353.84%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,017	100.0 %	1,180	100.0 %	+15.94%

Managers	Title	Age	Since
Jian Dong Yuan CEO	Chief Executive Officer	54	25/10/01
Yuan Lai Zou DFI	Director of Finance/CFO	53	31/12/10
Fan Hang BRD	Director/Board Member	38	31/12/05
Yang Qing Huang BRD	Director/Board Member	43	31/12/08
Jing Yan Song IRC	Investor Relations Contact	28	30/09/21
Nan Ding SEC	Corporate Secretary	33	19/04/21
Kai Li PRN	Corporate Officer/Principal	48	31/12/06

Members of the board	Title	Age	Since
Jian Dong Yuan CEO	Chief Executive Officer	54	25/10/01
Kai Li PRN	Corporate Officer/Principal	48	31/12/06
Ying Xian Shen BRD	Director/Board Member	38	17/09/17
Li Zhang BRD	Director/Board Member	42	28/02/09
Lei Su BRD	Director/Board Member	36	30/04/17
Ruyi He BRD	Director/Board Member	63	17/09/23
Xing He CHM	Chairman	41	31/03/20
Jing Fu He BRD	Director/Board Member	39	31/01/15
Fan Hang BRD	Director/Board Member	38	31/12/05
Dong Dong Xu BRD	Director/Board Member	-	17/09/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	422,466,561	203,822,261 ( 48.25 %)	0	48.25 %

Name	Equities	%	Valuation
Jian Dong Yuan 27.69 %	113,535,123	27.69 %	486 M ¥
Suzhou Borui Xinwen Management Consultancy LP 6.537 %	26,801,844	6.537 %	115 M ¥
Wei Fang Zhong 5.498 %	22,543,669	5.498 %	96 M ¥
SDIC Innovation Investment Management Co. Ltd. 4.540 %	18,612,863	4.540 %	80 M ¥
Hongshan 3.355 %	13,757,411	3.355 %	59 M ¥
Wanjia Asset Management Co., Ltd. 2.789 %	11,433,872	2.789 %	49 M ¥
HuaAn Fund Management Co., Ltd. 2.027 %	8,312,666	2.027 %	36 M ¥
Huatai Zijin Investment Co., Ltd. 1.747 %	7,162,037	1.747 %	31 M ¥
China Merchants Fund Management Co., Ltd. 1.742 %	7,143,509	1.742 %	31 M ¥
Suzhou Gaoquan Venture Investment LP 1.410 %	5,780,426	1.410 %	25 M ¥

BrightGene Bio-Medical Technology Co., Ltd.

Suzhou Industrial Park Building C25

215123, Suzhou

http://www.bright-gene.com

address BrightGene Bio-Medical Technology Co., Ltd.(688166)

Company calendar

	1st Jan change	Capi.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.	+1.51%	2.07B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals